Active Shortage

ACETAZOLAMIDE FOR INJECTION, USP

STERIMAX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ACETAZOLAMIDE FOR INJECTION, USP in Canada?

Yes. ACETAZOLAMIDE FOR INJECTION, USP 500MG has an active shortage reported to Health Canada (last updated January 23, 2025).

When will ACETAZOLAMIDE FOR INJECTION, USP be available again?

The manufacturer's estimated resolution date is January 1, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products · 1 same form & route

Expected resolution~2 months remaining (estimate)

Affected strength500MG

Report last updated2025-01-23

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

ACETAZOLAMIDE FOR INJECTION USP

MARCAN PHARMACEUTICALS INC

500MG · DIN 02537893

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

ACETAZOLAMIDE

AA PHARMA INC

250MG · DIN 00545015

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2027-01-01

~2 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02358328

Strength

500MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

ACETAZOLAMIDE

Tier

Unrated

Last Updated

2025-01-23

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from STERIMAX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02538431

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02456524

APRESOLINE

20MG · DIN 00723754

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02492768

AZITHROMYCIN FOR INJECTION USP

500MG · DIN 02483890

BACIJECT

50000UNIT · DIN 02245571